海外の治験の状況「1」での検索結果
8300件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Effect of oral MgSo4 administration on plasma ox-LDL, LOX-1 and lipid profiles in atherosclerosis patients
- Patients with high blood pressure and Hyperlipidemic with a small plaque in one of the coronary arteries. Atherosclerotic heart disease of native coronary artery without angina pectoris;I25.10
- Iran (Islamic Republic of)
- 2018-07-28
Recruiting
- A Study to Evaluate SHR-1210 in Combination With FOLFOX4 Regimen as First-Line Therapy in Subjects With Advanced HCC
- Advanced Hepatocellular Carcinoma
- China
- 2018-07-22
Recruiting
- Phase I / IIa clinical trial for patients with hepatitis C or B virus derived liver cirrhosis by CBP / beta catenin inhibitor PRI-724
- HCV or HBV liver cirrhosis
- Japan
- 2018-07-18
Recruiting
- Jiedu Granule in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- Hepatocellular carcinoma
- China
- 2018-07-16
Recruiting
- Huaier Granule in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- Hepatocellular carcinoma
- China
- 2018-07-11
Recruiting
- Evaluation of Third-line cART Regimen in Cambodia (3DICAM)
- HIV/AIDS
- Cambodia
- 2018-07-06
Recruiting
- 1st Line Durvalumab in PS 2 NSCLC Patients
- NSCLC Stage IV;NSCLC Stage IIIB
- Switzerland
- 2018-07-03
Recruiting
- A multicenter controlled phase II clinical study on oral administration of amlotinib after first-line treatment of ovarian cancer
- Ovarian cancer
- China
- 2018-07-02
Recruiting
- IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC
- NSCLC
- Germany, Spain, United Kingdom
- 2018-05-14
Recruiting
- Afatinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring active EGFR mutations : an open-label, randomized, multicenter, phase II study
- Non-squamous non-small cell lung cancer
- Japan
- 2017-06-18
Recruiting
- A randomized controlled study for the treatment of advanced hepatocellular carcinoma with anrotinib hydrochloride capsule alone or in combination with the first-line treatment with sergio
- Heaptocellular Carcinoma,HCC
- China
- 2019-03-26
Recruiting
- The efficacy of third or fourth line H. pylori eradication therapy with refabutin-amoxicillin-vonaprazan 7day regimen
- Helicobacter pylori infection
- None
- 2019-03-18
Recruiting
- First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study
- Esophageal Neoplasms
- China
- 2019-03-18
Recruiting
- A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
- Multiple Myeloma
- Italy
- 2019-03-13
Recruiting
- Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients
- Non Small Cell Lung Cancer
- China
- 2019-03-12
Recruiting
- evaluation the effect of botulinum toxin type A for treating frown lines
- skin rejuvenation.
- Iran (Islamic Republic of)
- 2019-01-30
Recruiting
- The CHYMASE Angiotensin-(1-12) Axis in Cardiovascular Disease
- Cardiovascular Disease
- United States
- 2019-01-30
Recruiting
- Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
- Moderate to Severe Glabellar Frown Lines
- Germany, United States
- 2019-01-15
Recruiting
- First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational Studies
- Lung Cancer
- Denmark, Lithuania, Norway, Sweden
- 2019-01-11
Recruiting
- Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication
- Helicobacter Pylori Infection;Helicobacter Gastritis;Helicobacter-Associated Pyloric Ulcer
- Taiwan
- 2019-01-10